Login / Signup
Mei-Sze Chua
Scopus Author ID
ORCID
Publication Activity (10 Years)
Years Active: 2019-2023
Publications (10 Years): 3
Top Topics
Ejection Fraction
Hepatitis B Virus
Gold Nanoparticles
Placebo Controlled
Top Venues
Cancer management and research
Liver international : official journal of the International Association for the Study of the Liver
Scientific reports
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Faiz Ahmad
,
Li Ma
,
Wei Wei
,
Yi Liu
,
Isaac Hakim
,
Aaron Daugherty
,
Sana Mujahid
,
Andrew A Radin
,
Mei-Sze Chua
,
Samuel So
Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma.
Liver international : official journal of the International Association for the Study of the Liver
(2023)
Mao Zhang
,
Mei-Sze Chua
,
Jie Hu
,
Haoran Li
,
Shun Zhang
,
Liqun Wu
,
Bing Han
High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection.
Cancer management and research
11 (2019)
Adi Wijaya Gani
,
Wei Wei
,
Run-Zhang Shi
,
Elaine Ng
,
Mindie Nguyen
,
Mei-Sze Chua
,
Samuel So
,
Shan X Wang
An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics.
Scientific reports
9 (1) (2019)